These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24890946)

  • 1. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
    Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
    BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
    Fujiwara Y; Ito K; Takamura A; Nagata K
    J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
    Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
    Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
    Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
    Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.
    Nara M; Komatsuda A; Itoh F; Kaga H; Saitoh M; Togashi M; Kameoka Y; Wakui H; Takahashi N
    Intern Med; 2017; 56(10):1247-1252. PubMed ID: 28502946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab.
    Wakiya R; Kameda T; Takeuchi Y; Ozaki H; Nakashima S; Shimada H; Kadowaki N; Dobashi H
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):145-151. PubMed ID: 33269653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.
    Yamaga Y; Tokuyama K; Kato T; Yamada R; Murayama M; Ikeda T; Yamakita N; Kunieda T
    Intern Med; 2016; 55(2):185-90. PubMed ID: 26781021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TAFRO syndrome with primary Sjogren's syndrome].
    Iwanaga N; Harada K; Tsuji Y; Kawahara C; Kurohama K; Izumi Y; Yoshida S; Fujikawa K; Ito M; Kawakami A; Migita K
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(5):478-484. PubMed ID: 27795506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
    Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
    Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
    Hiramatsu S; Ohmura K; Tsuji H; Kawabata H; Kitano T; Sogabe A; Hashimoto M; Murakami K; Imura Y; Yukawa N; Yoshifuji H; Fujii T; Takaori-Kondo A; Mimori T
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):64-71. PubMed ID: 27181237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.
    Tanaka M; Tsujimoto H; Yamamoto K; Shimoda S; Oka K; Takeoka H
    Medicine (Baltimore); 2017 Oct; 96(40):e8216. PubMed ID: 28984775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
    Minomo S; Fujiwara Y; Sakashita S; Takamura A; Nagata K
    J Med Case Rep; 2021 Jan; 15(1):3. PubMed ID: 33402219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of Thrombocytopenia, Anasarca (Edema, Pleural Effusion, and Ascites), Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Initially Not Presenting With Thrombocytopenia: A Role of Immature Platelet Fraction.
    Kanda M; Kitamura K; Saito A; Hayashi K; Suzuki T
    Cureus; 2024 Apr; 16(4):e58772. PubMed ID: 38779246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim: a case report.
    Noda-Narita S; Sumida K; Sekine A; Hoshino J; Mise K; Suwabe T; Hayami N; Yamanouchi M; Ueno T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Ohashi K; Fujii T; Ubara Y
    CEN Case Rep; 2018 May; 7(1):162-168. PubMed ID: 29468524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.
    Kikuchi T; Shimizu T; Toyama T; Abe R; Okamoto S
    Intern Med; 2017 Aug; 56(16):2205-2211. PubMed ID: 28781319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
    Zhou Q; Zhang Y; Zhou G; Zhu J
    BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
    Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
    Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAFRO syndrome: A disease that known is half cured.
    Chen T; Feng C; Zhang X; Zhou J
    Hematol Oncol; 2023 Aug; 41(3):310-322. PubMed ID: 36148768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TAFRO syndrome showing cholangitis on liver biopsy].
    Nagai Y; Ando S; Honda N; Noguchi H; Maemori M; Hayashi T; Sakai H
    Rinsho Ketsueki; 2016; 57(12):2490-2495. PubMed ID: 28090015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.